Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Aetna Inc. (AET)?

Page 1 of 2

Is Aetna Inc. (NYSE:AET) a superb investment right now? Investors who are in the know are betting on the stock. The number of long hedge fund positions improved by 7 recently.

Aetna Inc. (NYSE:AET)

In the financial world, there are many gauges market participants can use to track publicly traded companies. A couple of the most useful are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite money managers can outpace their index-focused peers by a superb margin (see just how much).

Just as key, positive insider trading sentiment is another way to break down the investments you’re interested in. As the old adage goes: there are lots of reasons for an executive to sell shares of his or her company, but just one, very clear reason why they would initiate a purchase. Plenty of academic studies have demonstrated the market-beating potential of this strategy if you understand where to look (learn more here).

With these “truths” under our belt, let’s take a peek at the recent action regarding Aetna Inc. (NYSE:AET).

How have hedgies been trading Aetna Inc. (NYSE:AET)?

At the end of the first quarter, a total of 54 of the hedge funds we track were long in this stock, a change of 15% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, David Einhorn’s Greenlight Capital had the biggest position in Aetna Inc. (NYSE:AET), worth close to $332.8 million, accounting for 5.1% of its total 13F portfolio. The second largest stake is held by John Paulson of Paulson & Co, with a $332.3 million position; 1.9% of its 13F portfolio is allocated to the company. Other hedge funds with similar optimism include Daniel S. Och’s OZ Management, Barry Rosenstein’s JANA Partners and William B. Gray’s Orbis Investment Management.

Now, specific money managers were breaking ground themselves. Viking Global, managed by Andreas Halvorsen, assembled the biggest position in Aetna Inc. (NYSE:AET). Viking Global had 65.6 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also made a $52.1 million investment in the stock during the quarter. The following funds were also among the new AET investors: SAC Subsidiary’s CR Intrinsic Investors, Dmitry Balyasny’s Balyasny Asset Management, and Curtis Schenker and Craig Effron’s Scoggin.

Insider trading activity in Aetna Inc. (NYSE:AET)

Insider trading activity, especially when it’s bullish, is most useful when the primary stock in question has seen transactions within the past half-year. Over the last half-year time frame, Aetna Inc. (NYSE:AET) has experienced 1 unique insiders purchasing, and 7 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Aetna Inc. (NYSE:AET). These stocks are Express Scripts Holding Company (NASDAQ:ESRX), Coventry Health Care, Inc. (NYSE:CVH), Humana Inc (NYSE:HUM), WellPoint, Inc. (NYSE:WLP), and CIGNA Corporation (NYSE:CI). This group of stocks belong to the health care plans industry and their market caps are closest to AET’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!